- Home
- INBK vs MIST Comparison
INBK vs MIST Comparison
Compare INBK & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBK | MIST |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.2M | 163.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | INBK | MIST |
|---|---|---|
| Price | $19.73 | $2.68 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $28.67 | $6.33 |
| AVG Volume (30 Days) | 86.4K | ★ 3.5M |
| Earning Date | 01-21-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.22% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $46,731,000.00 | N/A |
| Revenue This Year | $4.47 | N/A |
| Revenue Next Year | $25.08 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.05 | $0.63 |
| 52 Week High | $42.75 | $2.77 |
Technical Indicators
Market Signals| Indicator | INBK | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 70.83 |
| Support Level | $18.51 | $2.52 |
| Resistance Level | $20.50 | $2.75 |
| Average True Range (ATR) | 0.87 | 0.19 |
| MACD | 0.30 | 0.03 |
| Stochastic Oscillator | 78.84 | 86.54 |
Price Performance
Historical ComparisonAbout INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).